Substances that inhibit DHODH, such as the metabolite teriflunomide, are utilized in the form of immunomodulatory drugs in autoimmune disorders, such as rheumatoid/psoriatic arthritis and multiple sclerosis [22]. Here, DHODH is linked to psoriatic arthritis.